Minerva Neurosciences (NERV) EBITDA Margin (2014 - 2020)
Minerva Neurosciences (NERV) posted EBITDA Margin of 4.52% for FY2020.
Powered by 
Analysis
Minerva Neurosciences (NERV) EBITDA Margin (2014 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 39.16% |
| 10 | Minerva Neurosciences | 117.90 Mn | -130.03 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 71.77% |
| Dec 31, 2014 | -248,067,000.00% |
API Access
Minerva Neurosciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();